As of 2025-11-18, the Fair Value of Valbiotis SA (ALVAL.PA) is -2.11 EUR. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.59 EUR, the upside of Valbiotis SA is -461.54%.
With the market price of 0.59 EUR and our fair value calculation, Valbiotis SA (ALVAL.PA) is not a good investment. Investing in ALVAL.PA stocks now will result in a potential loss of 461.54%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -3.83 | -8.68 | -12.31 | -7.37 | -10.03 | -8.44 |
| YoY growth | 30.43% | -126.72% | -41.83% | 40.16% | -36.06% | -26.80% |
| Market Cap (mil) | 13.86 |
| P/E | |
| Forward P/E |
| EPS | -0.42 |
| Avg earnings growth rate | -26.80% |
| TTM earnings | -10.03 |